<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="iso-abbrev">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="publisher-id">ECAM</journal-id><journal-title-group><journal-title>Evidence-based Complementary and Alternative Medicine : eCAM</journal-title></journal-title-group><issn pub-type="ppub">1741-427X</issn><issn pub-type="epub">1741-4288</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7519996</article-id><article-id pub-id-type="doi">10.1155/2020/3678469</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Effect of Aqueous Extract of <italic>Adansonia digitata</italic> Stem Bark on the Development of Hypertension in L-NAME-Induced Hypertensive Rat Model</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2242-8350</contrib-id><name><surname>Ntchapda</surname><given-names>Fid&#x000e8;le</given-names></name><email>ntchapda71@yahoo.fr</email><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bonabe</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6788-0351</contrib-id><name><surname>Atsamo</surname><given-names>Albert Donatien</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kemeta Azambou</surname><given-names>David Romain</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bekono Fouda</surname><given-names>Yannick</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Imar Djibrine</surname><given-names>Soudy</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Seke Etet</surname><given-names>Paul F.</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Th&#x000e9;ophile</surname><given-names>Dimo</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Department of Biological Sciences, Faculty of Sciences, University of Ngaound&#x000e9;r&#x000e9;, P.O. Box 454, Ngaound&#x000e9;r&#x000e9;, Cameroon</aff><aff id="I2">
<sup>2</sup>Department of Animal Biology and Physiology, Laboratory of Animal Physiology, University of Yaound&#x000e9; I, P.O. Box 812, Yaound&#x000e9;, Cameroon</aff><aff id="I3">
<sup>3</sup>Institut Universitaire des Sciences et Techniques d'Ab&#x000e9;ch&#x000e9; (IUSTA), P.O. Box 6077, N'Djamena, Chad</aff><aff id="I4">
<sup>4</sup>Department of Physiological Sciences and Biochemistry, FMBS, University of Ngaound&#x000e9;r&#x000e9;, Ngaound&#x000e9;r&#x000e9;, P.O. Box 454, Cameroon</aff><author-notes><fn fn-type="other"><p>Academic Editor: Luca Vanella</p></fn></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>18</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>18</day><month>9</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>2020</volume><elocation-id>3678469</elocation-id><history><date date-type="received"><day>18</day><month>4</month><year>2020</year></date><date date-type="rev-recd"><day>23</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>10</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Fid&#x000e8;le Ntchapda et al.</copyright-statement><copyright-year>2020</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background</title><p>
<italic>Adansonia digitata</italic> is a plant used against cardiovascular disorders in African folk medicine. We assessed the effects of the aqueous extract of its stem bark on the development of hypertension in L-NAME-induced hypertensive rats. </p></sec><sec><title>Methods</title><p> The animals were administered L-NAME once daily for 3 weeks (25&#x02009;mg/kg, i.p.), concomitantly with aqueous extract of <italic>A. digitata</italic> stem bark (100 and 200&#x02009;mg/kg, p.o.) or captopril (20&#x02009;mg/kg, p.o.). Then, hemodynamic and electrocardiographic parameters, oxidative stress markers, and the lipid profile were assessed in the blood and heart, aorta, and kidney homogenates, and histopathological analyses were performed. </p></sec><sec><title>Results</title><p> L-NAME-induced hypertensive control animals, but not the animals concomitantly treated with <italic>A. digitata</italic> extract, displayed increases in the mean arterial blood pressure (21.64% difference, <italic>p</italic> &#x0003c; 0.001, vs. dose 200&#x02009;mg/kg), systolic arterial blood pressure (21.33%, <italic>p</italic> &#x0003c; 0.001), and the diastolic arterial blood pressure (21.84%, <italic>p</italic> &#x0003c; 0.001). In addition, hypertensive control animals displayed (i) increases in serum triglycerides, total cholesterol, LDL, and creatinine levels, malondialdehyde and transaminase activities, and atherogenic index; (ii) decreases in serum HDL, catalase, reduced glutathione, and nitric oxide; and (iii) aorta wall thickening, inflammatory cell infiltration, and cell loss in the cardiac muscle and renal tissues. As captopril, the extract prevented hypertension-like changes in lipid profile, cardiac, hepatic, and renal affection indicators, and oxidative stress markers. </p></sec><sec><title>Conclusion</title><p> Our findings suggest that the extract of <italic>A. digitata</italic> has antihypertensive and antioxidant effects in L-NAME-induced hypertension rat models. These effects partly justify the traditional medicine use against cardiovascular disorders.</p></sec></abstract><funding-group><award-group><funding-source>University of Ngaound&#x000e9;r&#x000e9;</funding-source></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>High blood pressure (hypertension) is a major driver of cardiovascular diseases which can lead to life-threatening conditions such as myocardial infarction, coronary heart failure, renal failure, and stroke [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>]. The incidence of hypertension has been increasing worldwide, particularly in developing countries. For instance, from 80 million adults in the early 2000s, the number of hypertension cases in sub-Saharan Africa is expected to rise to 150 million by 2025 [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>]. The pathogenetic mechanisms of hypertension encompass complex interactions of signaling pathways and genetic and environmental factors.</p><p>Nonetheless, it is well-established that oxidative stress contributes to the development of hypertension through nitric oxide (NO) deficiency [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>]. The vascular endothelial cells' product NO is a potent vasodilator with important roles in the growth and resistance of blood vessels [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>]. NO synthase inhibitors induce endothelial dysfunction and oxidative stress by decreasing NO activity. Subchronic administration of laboratory rodents with NO synthase inhibitors, such as N-nitro-L-arginine methyl ester (L-NAME), results in chronic hypertension [<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>], hence the common use of this chemical for developing hypertension experimental models.</p><p>Beyond the pathogenesis, the management of hypertension without marked undesired effects and consequently with high patient adherence is challenging [<xref rid="B5" ref-type="bibr">5</xref>&#x02013;<xref rid="B8" ref-type="bibr">8</xref>]. Novel therapeutics are direly needed in the field, and medicinal plants are a potential source. <italic>Adansonia digitata</italic> L. (&#x0201c;African baobab&#x0201d;) is a medicinal plant of the order of Malvales (the Bombaceae family), which is commonly used by African traditional healers for the management of cardiovascular disorders [<xref rid="B11" ref-type="bibr">11</xref>]. <italic>A. digitata</italic> is a big iconic and culturally significant tree found in savannahs of sub-Saharan Africa, which is popularly nicknamed as &#x0201c;the small pharmacy tree&#x0201d; due to its numerous uses in folk medicine [<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>]. The plant was reported anti-inflammatory, antioxidant, antimalarial, and antimicrobial properties [<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>]. The stem bark contains a semifluid gum that is used in folk medicine to clean wounds, to promote weight gain, and as growth food for infants [<xref rid="B16" ref-type="bibr">16</xref>]. An alkaloid isolated from the stem bark and termed as &#x0201c;adansonine&#x0201d; was reported to account at least partly for antimalarial [<xref rid="B17" ref-type="bibr">17</xref>] and antidepressant properties [<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>]. The fruits of <italic>A. digitata</italic> were reported cardioprotective properties against isoproterenol-induced cardiac damage [<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>]. However, despite the traditional use against cardiovascular diseases, data are lacking on the effects of the plant on hypertension, a major driver of these diseases.</p><p>In the present study, we assessed the effect of the aqueous extract of <italic>A. digitata</italic> stem bark on the development of hypertension in L-NAME-induced hypertensive rats.</p></sec><sec id="sec2"><title>2. Material and Methods</title><sec id="sec2.1"><title>2.1. Animal Material</title><p>Adult male Wistar albino rats (<italic>N</italic>&#x02009;=&#x02009;30, about 9-weeks old, 150&#x02013;160&#x02009;g) were obtained from the animal facility of the Faculty of Science (FS), University of Ngaound&#x000e9;r&#x000e9;. They were housed under 25&#x02009;&#x000b1;&#x02009;1&#x000b0;C room temperature, 43&#x02009;&#x000b1;&#x02009;10% relative humidity, and 12&#x02009;:&#x02009;12&#x000b0;h light/dark cycle, in a room of the Laboratory of Medicinal Plants, Health and Galenic Formulation, Department of Biological Sciences (FS), University of Ngaound&#x000e9;r&#x000e9;. The animals had free access to standard diet and tap water.</p><p>The experimental protocol was approved by the Institutional Animal Ethics Committee (reference no. FWIRB 00001954). Research activities were conducted following European Community guidelines for laboratory animal use and care (86/609/EEC).</p></sec><sec id="sec2.2"><title>2.2. Experimental Design</title><p>The rats were randomly divided into five groups (<italic>N</italic>&#x02009;=&#x02009;6 per group). After one week of acclimation to laboratory conditions, for three consecutive weeks and once daily, the animals were administered with either physiological solution (NaCl 0.9% in a volume of 0.5&#x02009;ml/100&#x02009;g, i.p.) (the normotensive control group) or L-NAME (25&#x02009;mg/kg in a volume of 0.5&#x02009;ml/100&#x02009;g, i.p.) (hypertensive-like groups). The latter groups concomitantly received either the physiological solution in a volume of 0.5&#x02009;ml/100&#x02009;g (i.p.) (the hypertensive control group), the antihypertensive drug captopril (20&#x02009;mg/kg, in a volume of 1&#x02009;mL/100&#x02009;g, p.o.) (the positive control group), or a dose of the aqueous extract of <italic>A. digitata</italic> (100 or 200&#x02009;mg/kg in a volume of 1&#x02009;mL/100&#x02009;g, p.o.) (test groups). The body weight was measured every two days.</p><p>At the end of the 3 weeks of L-NAME daily administration, the animals were anesthetized and the femoral artery exposed by dissection to measure the blood pressure and the heart rate. Then, the arteriovenous blood was collected in heparinized tubes and animals were sacrificed. The aorta, kidney, and heart were dissected out. Fats and other connective tissues were removed, and organs were weighed. Samples were processed for biochemical tests and histopathological studies.</p></sec><sec id="sec2.3"><title>2.3. Plant Extract Preparation</title><p>The stem bark of <italic>A. digitata</italic> was harvested in the town of Maroua, Diamar&#x000e9;, Far North Region (Cameroon), in November 2017. A sample was identified, authenticated, and stored (Cameroon National Herbarium Specimen No 42417/HNC, Yaound&#x000e9;). Stem bark peels were air-dried at room temperature, grounded to powder using an electric blender, and stored in a glass container. About 100&#x02009;g of the powder was macerated in 1000&#x02009;mL of distilled water for 24 hours. The solution was filtered using Wattman No. 3 paper. Then, the filtrate was evaporated using an oven (45&#x000b0;C). The solid extract obtained (yield: 31.4%) was stored at 4&#x000b0;C. Every day, the solid extract was used to prepare fresh solutions for the oral administration of the doses 100 and 200&#x02009;mg/kg of extract in a volume of 1&#x02009;mL/100&#x02009;g (p.o.).</p></sec><sec id="sec2.4"><title>2.4. Hemodynamic and Electrocardiographic Measurements</title><p>The animals were deeply anesthetized (urethane, 1.5&#x02009;g/kg, i.p.). The trachea was exposed and cannulated to ensure normal respiration, while the femoral artery was exposed, cannulated, and flushed with 1&#x02009;ml of heparinized Mc Even buffer. Then, the blood pressure and the heart rate were measured by connecting the cannulated femoral artery to a computerized system including an arterial cannula connected to a pressure transducer coupled with a hemodynamic recorder (MP35, Biopac Student Lab, Goleta, CA, USA).</p></sec><sec id="sec2.5"><title>2.5. Biochemical Tests</title><sec id="sec2.5.1"><title>2.5.1. Blood Samples</title><p>The arteriovenous blood collected was centrifuged (3000&#x02009;rpm, 15&#x02009;min, 4&#x000b0;C), and the plasma was separated and used for biochemical analyses. Triglycerides and LDL-, HDL-, and total cholesterol were determined using GIESSE kit, according to the instructions of the manufacturer (GIESSE Diagnostics, Roma, Italy). Standard biochemical methods were used to measure plasma levels of proteins, transaminases, urea, and creatinine [<xref rid="B22" ref-type="bibr">22</xref>&#x02013;<xref rid="B24" ref-type="bibr">24</xref>]. The atherogenic index (AI) was calculated as follows:</p><p>AI&#x000b0;=&#x000b0;([total cholesterol]&#x02009;&#x02212;&#x02009;[HDL&#x02009;&#x02212;&#x02009;cholesterol])/[HDL&#x02009;&#x02212;&#x02009;cholesterol] [<xref rid="B25" ref-type="bibr">25</xref>].</p></sec><sec id="sec2.5.2"><title>2.5.2. Organ Homogenates</title><p>Samples of the aorta, kidney, and heart tissues were homogenized (20%&#x000b0;w/v) in Tris-HCl buffer (kidney) or in Mc Even buffer (heart and aorta). The homogenates obtained were centrifuged (4000&#x02009;rpm, 25&#x02009;min, 4&#x000b0;C). The supernatant was collected and processed for the analysis of antioxidant enzyme activities. Standard biochemical techniques were used to measure the activities of reduced glutathione (GSH) [<xref rid="B26" ref-type="bibr">26</xref>] and catalase [<xref rid="B27" ref-type="bibr">27</xref>], the nitrite content [<xref rid="B28" ref-type="bibr">28</xref>], and the malondialdehyde concentration [<xref rid="B29" ref-type="bibr">29</xref>].</p></sec></sec><sec id="sec2.6"><title>2.6. Histopathological Analyses</title><p>Samples of the aorta, the heart, and kidney were fixed in 10% buffered formaldehyde and processed for paraffin embedding. Then, they were cut using a microtome (section thickness: 4&#x02009;<italic>&#x003bc;</italic>m), and sections were stained using H&#x00026;E. Histopathological changes were characterized by analyzing the sections stained under a computerized microscope equipped with a camera (Olympus, Hamburg, Germany).</p></sec><sec id="sec2.7"><title>2.7. Statistical Analysis</title><p>The results were analyzed using Microsoft Excel 2019 and GraphPad Prism software (version 7.0). Data obtained in the test groups and in the positive control group were compared with those obtained in the normotensive control group and in the hypertensive control group. The statistical significance of differences was assessed using one-way ANOVA followed by Tukey <italic>post hoc</italic> test for intergroup comparisons. Differences with <italic>p</italic> value&#x02009;&#x0003c;&#x02009;0.05 were significant. Data were presented as mean&#x02009;&#x000b1;&#x02009;SEM.</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. Body Weight and Cardiovascular Properties</title><sec id="sec3.1.1"><title>3.1.1. Body and Organ Weights</title><p>
<xref rid="tab1" ref-type="table">Table 1</xref> presents the changes in body weight before and after 3 weeks of concomitant treatment with L-NAME and either the aqueous extract of <italic>A. digitata</italic> or captopril. A marked decrease in body weight growth was observed in the hypertensive control group (<xref rid="tab1" ref-type="table">Table 1</xref>). The aqueous extract at all doses tested and captopril mitigated this decrease. Gains of 23.36% (<italic>p</italic> &#x0003c; 0.05), 94.13% (<italic>p</italic> &#x0003c; 0.001), and 27.02% (<italic>p</italic> &#x0003c; 0.05) were observed with doses 100 and 200&#x02009;mg/kg, and captopril, respectively, was compared to the hypertensive control group (<xref rid="tab1" ref-type="table">Table 1</xref>).</p><p>
<xref rid="tab1" ref-type="table">Table 1</xref> also shows the effects of concomitant treatment with L-NAME and either the aqueous extract of <italic>A. digitata</italic> or captopril on the relative weight of the heart, the left ventricle, and kidneys. The relative weights of the heart and of left ventricle were increased significantly (27.67 %, <italic>p</italic> &#x0003c; 0.05, and 48.07%, <italic>p</italic> &#x0003c; 0.001, respectively) in hypertensive control animals (<xref rid="tab1" ref-type="table">Table 1</xref>). Treatment with captopril and plant extract doses 100 and 200&#x02009;mg/kg mitigated this increase (<xref rid="tab1" ref-type="table">Table 1</xref>). Relative weight of kidneys was also increased significantly in the hypertensive control group (0.79&#x02009;&#x000b1;&#x02009;0.05 vs. 0.59&#x02009;&#x000b1;&#x02009;0.05&#x02009;g/100&#x02009;g BW in the normotensive control group, <italic>p</italic> &#x0003c; 0.05) (<xref rid="tab1" ref-type="table">Table 1</xref>). This detrimental change was prevented in groups receiving the extract at doses 100 or 200&#x02009;mg/kg, or captopril (<italic>p</italic> &#x0003c; 0.05) (<xref rid="tab1" ref-type="table">Table 1</xref>).</p></sec><sec id="sec3.1.2"><title>3.1.2. Blood Pressure and Heart Rate</title><p>
<xref rid="tab2" ref-type="table">Table 2</xref> presents the systolic arterial blood pressure (SBP), the diastolic arterial blood pressure (DBP), the mean arterial blood pressure (MABP), and the heart rate of animals treated daily and concomitantly with L-NAME and either the aqueous extract of <italic>A. digitata</italic> or captopril for 3&#x02009;weeks. The SBP, DBP, and MBP were markedly increased in the hypertensive control group compared to the normotensive control group (<italic>p</italic> &#x0003c; 0.001) (<xref rid="tab2" ref-type="table">Table 2</xref>). Treatment with the aqueous extract of <italic>A. digitata</italic> at doses 100 and 200&#x02009;mg/kg and with captopril mitigated this change (<italic>p</italic> &#x0003c; 0.001 vs. the hypertensive control group and <italic>p</italic> &#x0003c; 0.05 vs. normotensive controls) with differences in SBP, DBP, and MBP of (<xref rid="tab2" ref-type="table">Table 2</xref>): (i) 8.89 %, 6.44%, and 8.23% with extract dose 100&#x02009;mg/kg, respectively (compared to the hypertensive control group); (ii) 21.33%, 21.84%, and 21.64% with extract dose 200&#x02009;mg/kg, respectively; and (iii) 22.33%, 19.43%, and 20.45% with captopril, respectively.</p><p>The heart rate was also markedly increased in the hypertensive control group compared to the normotensive control group (<italic>p</italic> &#x0003c; 0.001) (<xref rid="tab2" ref-type="table">Table 2</xref>). Treatment with the aqueous extract of <italic>A. digitata</italic> at doses 100 and 200&#x02009;mg/kg and with captopril prevented this change and maintained the heart rate close to normotensive control values (<xref rid="tab2" ref-type="table">Table 2</xref>).</p></sec><sec id="sec3.1.3"><title>3.1.3. Electrocardiographic Parameters</title><p>
<xref rid="tab3" ref-type="table">Table 3</xref> presents the electrocardiographic parameters of animals treated daily and concomitantly with L-NAME and either the aqueous extract of <italic>A. digitata</italic> or captopril for 3&#x02009;weeks. Hypertensive control group, but not animals treated with the aqueous extract of A. digitata (100 and 200 mg/kg) or captopril, displayed marked increases in QRS interval duration, thus increasing the magnitude (<xref rid="tab3" ref-type="table">Table 3</xref>). In addition, the administration of the aqueous extract of <italic>A. digitata</italic> significantly prevented the decrease in the duration of the PR interval observed in the hypertensive control animals with 42.67&#x02009;&#x000b1;&#x02009;0.29&#x02009;ms in the group treated with the extract at dose 100&#x02009;mg/kg, and 49.33&#x02009;&#x000b1;&#x02009;0.58&#x02009;ms in the group treated with extract dose 200&#x02009;mg/kg, against 48.33&#x02009;&#x000b1;&#x02009;0.76&#x02009;ms in the hypertensive control group (i.e., decrease of 15.60% and 13.26%, respectively, <italic>p</italic> &#x0003c; 0.001) (<xref rid="tab3" ref-type="table">Table 3</xref>).</p><p>Unlike at 100&#x02009;mg/kg, at 200&#x02009;mg/kg the aqueous extract of <italic>A. digitata</italic> significantly prevented the reduction in the duration of the QRS complex observed in hypertensive control animals (44.30%, <italic>p</italic> &#x0003c; 0.05) (<xref rid="tab3" ref-type="table">Table 3</xref>). Both the doses of <italic>A. digitata</italic> extract (100 and 200&#x02009;mg/kg) and captopril prevented significantly the increase in the duration of the QT interval observed in the hypertensive control animals (65.3&#x02009;&#x000b1;&#x02009;1.0, 65.6&#x02009;&#x000b1;&#x02009;1.5, and 62.0&#x02009;&#x000b1;&#x02009;0.3, respectively, vs. 85.33&#x02009;&#x000b1;&#x02009;3.97, <italic>p</italic> &#x0003c; 0.01) (<xref rid="tab3" ref-type="table">Table 3</xref>). Also compared to hypertensive control animals, slight increases were observed in the RR interval duration of animals treated with the extract (169.67&#x02009;&#x000b1;&#x02009;0.76 with dose 100&#x02009;mg/kg and 156.00&#x02009;&#x000b1;&#x02009;1.00&#x02009;ms with dose 200&#x02009;mg/kg vs. 151.33&#x02009;&#x000b1;&#x02009;0.76&#x02009;ms in the hypertensive control group) (<xref rid="tab3" ref-type="table">Table 3</xref>).</p></sec></sec><sec id="sec3.2"><title>3.2. Oxidative Stress Markers and Lipid Profile</title><sec id="sec3.2.1"><title>3.2.1. Nitric Oxide and Malondialdehyde Levels</title><p>Figures <xref ref-type="fig" rid="fig1">1(a)</xref> and <xref ref-type="fig" rid="fig1">1(b)</xref> show the changes in nitric oxide (<xref ref-type="fig" rid="fig1">Figure 1(a)</xref>) and malondialdehyde (<xref ref-type="fig" rid="fig1">Figure 1(b)</xref>) levels of animals treated daily and concomitantly with L-NAME and either the aqueous extract of <italic>A. digitata</italic> or captopril for 3 weeks. Compared to normotensive control animals, the hypertensive control group displayed significant decreases in levels of nitric oxide in the aorta (18.80%, <italic>p</italic> &#x0003c; 0.05), in the heart (30.95%, <italic>p</italic> &#x0003c; 0.001), and in the kidney (29.73%, <italic>p</italic> &#x0003c; 0.05) tissues (<xref ref-type="fig" rid="fig1">Figure 1(a)</xref>). Treatments with extract doses 100 and 200&#x02009;mg/kg mitigated significantly the decreases in nitric oxide in the aorta (differences compared with the hypertensive control group: 30.30%, <italic>p</italic> &#x0003c; 0.01, and 57.39%, <italic>p</italic> &#x0003c; 0.001, respectively), in the heart (40.39%, <italic>p</italic> &#x0003c; 0.001, and 18.10%, not significant, respectively), and in the kidney (198.78%, <italic>p</italic> &#x0003c; 0.001, and 114.29%, <italic>p</italic> &#x0003c; 0.001, respectively) (<xref ref-type="fig" rid="fig1">Figure 1(a)</xref>). Captopril also mitigated significantly the decreases in nitric concentration in the aorta (64.53%, <italic>p</italic> &#x0003c; 0.001), in the heart (30.54%, <italic>p</italic> &#x0003c; 0.05), and in the kidney (16.72%, <italic>p</italic> &#x0003c; 0.05) compared to the hypertensive control (A).</p><p>Bars are mean&#x02009;&#x000b1;&#x02009;SEM (<italic>N</italic>&#x02009;=&#x02009;6 per group). ANOVA&#x02009;+&#x02009;the Tukey test: <sup>c</sup><italic>p</italic> &#x0003c; 0.05, <sup>b</sup><italic>p</italic> &#x0003c; 0.01, and <sup>a</sup><italic>p</italic> &#x0003c; 0.001 vs. the normotensive control group; <sup><italic>&#x003b4;</italic></sup><italic>p</italic> &#x0003c; 0.05, <sup><italic>&#x003b2;</italic></sup><italic>p</italic> &#x0003c; 0.01, and <sup><italic>&#x003b1;</italic></sup><italic>p</italic> &#x0003c; 0.001 vs. the diabetic control group. LN&#x02009;=&#x02009;N-nitro-L-arginine methyl ester.</p><p>As shown in <xref ref-type="fig" rid="fig1">Figure 1(b)</xref>, hypertensive control animals displayed significant increases in malondialdehyde levels in the aorta (53.48%, <italic>p</italic> &#x0003c; 0.01) and in the kidney (39.12%, <italic>p</italic> &#x0003c; 0.05), but not in the heart, as compared to the normotensive control group (<xref ref-type="fig" rid="fig1">Figure 1(b)</xref>). Compared to the hypertensive control animals, the rats concomitantly treated with L-NAME and dose 200&#x02009;mg/kg of <italic>A. digitata</italic> extract displayed significantly lower levels of malondialdehyde in the heart (37.22%, <italic>p</italic> &#x0003c; 0.01) and in the kidney (22.38%, <italic>p</italic> &#x0003c; 0.05) (<xref ref-type="fig" rid="fig1">Figure 1(b)</xref>). Also compared to the hypertensive control animals, the rats treated with extract dose 100&#x02009;mg/kg displayed significantly lower malondialdehyde levels (<italic>p</italic> &#x0003c; 0.001) in the aorta (32.43% difference) and in the heart (36.29%) (<xref ref-type="fig" rid="fig1">Figure 1(b)</xref>). Captopril did not induce any marked change in malondialdehyde tissue levels.</p></sec><sec id="sec3.2.2"><title>3.2.2. Catalase Activity and Reduced Glutathione Level</title><p>Figures <xref ref-type="fig" rid="fig1">1(c)</xref> and <xref ref-type="fig" rid="fig1">1(d)</xref> show the changes in reduced glutathione level (<xref ref-type="fig" rid="fig1">Figure 1(c)</xref>) and catalase activity (<xref ref-type="fig" rid="fig1">Figure 1(d)</xref>) levels of animals treated daily and concomitantly with L-NAME and either the aqueous extract of <italic>A. digitata</italic> or captopril for 3 weeks. Catalase activity was decreased in the aorta and in the heart of hypertensive control animals compared to the normotensive control group (<xref ref-type="fig" rid="fig1">Figure 1(c)</xref>). <italic>A. digitata</italic> (100 and 200&#x02009;mg/kg) treatment increased significantly the catalase activity in the aorta (68.68%, <italic>p</italic> &#x0003c; 0.01, and 75.68%, <italic>p</italic> &#x0003c; 0.001, respectively) and in the kidney (92.25%, <italic>p</italic> &#x0003c; 0.001, and 57.30%, <italic>p</italic> &#x0003c; 0.01) (<xref ref-type="fig" rid="fig1">Figure 1(c)</xref>). Treatment with captopril significantly increased catalase activity in the heart (86.64%, <italic>p</italic> &#x0003c; 0.001) and in the kidney (88.36%, <italic>p</italic> &#x0003c; 0.001) compared to the hypertensive control group (<xref ref-type="fig" rid="fig1">Figure 1(c)</xref>).</p><p>Hypertensive control animals displayed significant decreases in the glutathione levels in the aorta (29.51%, <italic>p</italic> &#x0003c; 0.001), in the heart (34.46%, <italic>p</italic> &#x0003c; 0.001), and in the kidney (29.11%, <italic>p</italic> &#x0003c; 0.001) compared to the normotensive control group (<xref ref-type="fig" rid="fig1">Figure 1(d)</xref>). The animals treated with the extract dose 200&#x02009;mg/kg significantly mitigated this decrease in the kidney (27.14%, <italic>p</italic> &#x0003c; 0.01, compared to hypertensive rats), while the animals treated with the dose 100&#x02009;mg/kg mitigated the decrease in the aorta (<italic>p</italic> &#x0003c; 0.01) and in the heart (<italic>p</italic> &#x0003c; 0.001) (<xref ref-type="fig" rid="fig1">Figure 1(d)</xref>). Captopril treatment also mitigated the decrease in reduced glutathione levels in the aorta (106.60%, <italic>p</italic> &#x0003c; 0.001) and in the kidney (28.07%, <italic>p</italic> &#x0003c; 0.01) (<xref ref-type="fig" rid="fig1">Figure 1(d)</xref>).</p></sec><sec id="sec3.2.3"><title>3.2.3. Blood Lipid Profile</title><p>
<xref rid="tab4" ref-type="table">Table 4</xref> presents the blood lipid profile of animals treated daily and concomitantly with L-NAME and either the aqueous extract of <italic>A. digitata</italic> or captopril for 3 weeks. The hypertensive control animals displayed significant (<italic>p</italic> &#x0003c; 0.05) increases in blood total cholesterol (23.31%), triglycerides (53.61%), LDL-cholesterol (61.31%), and decrease in HDL-cholesterol (63.04%) compared to the normotensive control group (<xref rid="tab4" ref-type="table">Table 4</xref>). Extract dose 200&#x02009;mg/kg significantly (<italic>p</italic> &#x0003c; 0.05) prevented the increases in total cholesterol (26.34% difference from the hypertensive control group) and in triglycerides (25.64% difference), and decrease in HDL-cholesterol (52.41% difference) (<xref rid="tab4" ref-type="table">Table 4</xref>). Captopril mitigated only slightly the increases in triglyceride, total cholesterol, and LDL-cholesterol, and decrease in HDL-cholesterol mediated by L-NAME treatment (<xref rid="tab4" ref-type="table">Table 4</xref>).</p><p>L-NAME treatment also increased the values of cardiac risk ratio (CRR) and atherogenic index (AI) (7.22 and 0.66, respectively) in hypertensive animals, compared to the normotensive control group (2.15 and 0.04, respectively) (<italic>p</italic> &#x0003c; 0.05) (<xref rid="tab4" ref-type="table">Table 4</xref>). <italic>A. digitata</italic> doses 100 and 200&#x02009;mg/kg prevented the development of these alterations (2.70 and 0.34 with 100&#x02009;mg/kg and 3.49 and 0.35 with 200&#x02009;mg/kg, <italic>p</italic> &#x0003c; 0.01) (<xref rid="tab4" ref-type="table">Table 4</xref>). Although in a lesser extent compared to the effects of the extract, captopril also prevented the increment in CRR and AI values (2.73 and 0.08, respectively, <italic>p</italic> &#x0003c; 0.05) (<xref rid="tab4" ref-type="table">Table 4</xref>).</p></sec></sec><sec id="sec3.3"><title>3.3. Markers of Liver and Kidney Functions</title><p>
<xref rid="tab5" ref-type="table">Table 5</xref> presents the changes in serum total protein, creatinine level, concentrations of sodium, potassium and chloride, and activities of ALAT and ASAT of animals treated daily and concomitantly with L-NAME and either the aqueous extract of <italic>A. digitata</italic> or captopril for 3 weeks.</p><sec id="sec3.3.1"><title>3.3.1. Liver Function</title><p>Hypertensive control animals displayed significant (<italic>p</italic> &#x0003c; 0.01) increases in serum total protein (79.10%), and ALAT (32.84%) and ASAT (53.99%) activities compared with the control group (<xref rid="tab5" ref-type="table">Table 5</xref>). Treatment with captopril or extract doses 100 and 200&#x02009;mg/kg significantly reduced (<italic>p</italic> &#x0003c; 0.001) ALAT and ASAT activities (27.87%, 30.69%, and 31.07%, and 57.42%, 47.23 %, and 49.69%, respectively) compared to hypertensive control group (<xref rid="tab5" ref-type="table">Table 5</xref>). The increase in blood total protein observed in the hypertensive control group was mitigated significantly (<italic>p</italic> &#x0003c; 0.01) in the groups treated with extract dose 100&#x02009;mg/kg (23.33% compared to the hypertensive control group), dose 200&#x02009;mg/kg (26.67%), and captopril (25.83%) (<xref rid="tab5" ref-type="table">Table 5</xref>).</p></sec><sec id="sec3.3.2"><title>3.3.2. Kidney Function</title><p>Serum sodium and chloride concentrations and serum creatinine level were significantly increased, while serum potassium concentration was decreased, in hypertensive control animals compared to the normotensive control group (20.86%, <italic>p</italic> &#x0003c; 0.001, 0.63%, <italic>p</italic> &#x0003c; 0.05, and &#x02212;46.55%, <italic>p</italic> &#x0003c; 0.001, respectively) (<xref rid="tab5" ref-type="table">Table 5</xref>). Concomitant treatment with captopril or the extract significantly mitigated the L-NAME-induced increases in concentrations of sodium and chloride and in the level of creatinine, as well as the decrease in potassium concentration (<xref rid="tab5" ref-type="table">Table 5</xref>).</p></sec></sec><sec id="sec3.4"><title>3.4. Histopathological Changes in the Aorta, Heart, and Kidney</title><p>
<xref ref-type="fig" rid="fig2">Figure 2</xref> shows micrographs of H&#x00026;E-stained sections of aortas, hearts, and kidneys of representative animals of the normotensive control group (Figures <xref ref-type="fig" rid="fig2">2(a)</xref>, <xref ref-type="fig" rid="fig2">2(e)</xref>, and <xref ref-type="fig" rid="fig2">2(i)</xref>), of the hypertensive control group (Figures <xref ref-type="fig" rid="fig2">2(b)</xref>, <xref ref-type="fig" rid="fig2">2(f)</xref>, and <xref ref-type="fig" rid="fig2">2(j)</xref>), and of animals treated concomitantly with L-NAME and either captopril (Figures <xref ref-type="fig" rid="fig2">2(c)</xref>, <xref ref-type="fig" rid="fig2">2(g)</xref>, and <xref ref-type="fig" rid="fig2">2(k)</xref>) or dose 200&#x02009;mg/kg of <italic>A. digitata</italic> extract (Figures <xref ref-type="fig" rid="fig2">2(d)</xref>, <xref ref-type="fig" rid="fig2">2(h)</xref>, and <xref ref-type="fig" rid="fig2">2(l)</xref>). Overall, histopathological analyses of sections of the aorta revealed a marked thickening in the arterial walls leading to the reduction of blood vessel diameter (<xref ref-type="fig" rid="fig2">Figure 2(b)</xref>). Histopathological analyses of renal tissue of hypertensive control animals revealed tubular clarification, fusion of the glomeruli with the capsule, and focal peritubular and marked periglomerular infiltration of inflammatory cells were observed (<xref ref-type="fig" rid="fig2">Figure 2(f)</xref>). Histopathological analyses of sections of cardiac muscle tissue of hypertensive control animals revealed a marked infiltration of inflammatory cells, massive cell loss, congestion of blood vessels, and focal hemorrhagic lesions (<xref ref-type="fig" rid="fig2">Figure 2(j)</xref>). Treatment with captopril (Figures <xref ref-type="fig" rid="fig2">2(c)</xref>, <xref ref-type="fig" rid="fig2">2(g)</xref>, and <xref ref-type="fig" rid="fig2">2(k)</xref>) or the aqueous extract of <italic>A. digitata</italic> (Figures <xref ref-type="fig" rid="fig2">2(d)</xref>, <xref ref-type="fig" rid="fig2">2(h)</xref>, and <xref ref-type="fig" rid="fig2">2(l)</xref>) mitigated the histopathological changes induced by L-NAME treatment in the aorta, the heart, and the kidney.</p><p>Micrographs of H&#x00026;E-stained section of aortas, hearts, and kidneys of representative animals of the normotensive control group (Figures <xref ref-type="fig" rid="fig2">2(a)</xref>, <xref ref-type="fig" rid="fig2">2(e)</xref>, and <xref ref-type="fig" rid="fig2">2(i)</xref>, respectively), of the hypertensive control group (Figures <xref ref-type="fig" rid="fig2">2(b)</xref>, <xref ref-type="fig" rid="fig2">2(f)</xref>, and <xref ref-type="fig" rid="fig2">2(j)</xref>, respectively), and of animals treated concomitantly with L-NAME (LN) and either captopril (Figures <xref ref-type="fig" rid="fig2">2(c)</xref>, <xref ref-type="fig" rid="fig2">2(g)</xref>, and <xref ref-type="fig" rid="fig2">2(k)</xref>, respectively) or dose 200&#x02009;mg/kg of <italic>Adansonia digitata</italic> extract (Figures <xref ref-type="fig" rid="fig2">2(d)</xref>, <xref ref-type="fig" rid="fig2">2(h)</xref>, and <xref ref-type="fig" rid="fig2">2(l)</xref>, respectively). Note that unlike animals of the other groups, the hypertensive control animal displayed a marked (about 3-fold) increase in the thickness of the aorta wall (<xref ref-type="fig" rid="fig2">Figure 2(b)</xref>), an inflammation in the kidney revealed by a marked infiltration of inflammatory cells (<xref ref-type="fig" rid="fig2">Figure 2(f)</xref>), and both a massive infiltration of immune cells and cell loss (black arrows) in the heart (<xref ref-type="fig" rid="fig2">Figure 2(j)</xref>; magnification, 100x).</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>The results of the present study suggest that the aqueous extract of stem bark of <italic>A. digitata</italic> had preventive effects on the development of hypertension in L-NAME-induced hypertensive rats. Treatment of animals with L-NAME resulted in significant increases in heart rate and systolic, diastolic, and mean arterial blood pressures, as well as a reduction in weight gain in hypertensive control animals, which is in accordance with the available information on this model [<xref rid="B30" ref-type="bibr">30</xref>&#x02013;<xref rid="B32" ref-type="bibr">32</xref>]. Concomitant treatment of animals with L-NAME and either the extract of <italic>A. digitata</italic> or the angiotensin-converting enzyme inhibitor captopril mitigated the blood pressure increase and prevented the reduction in weight gain observed in hypertensive control animals. L-NAME-induced dyslipidemia, which plays a pivotal role in the pathogenesis of hypertension in this model [<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>], was not observed in animals concomitantly treated with L-NAME and either <italic>A. digitata</italic> extract or captopril in the present study, unlike hypertensive control animals that displayed marked decrease in blood HDL-cholesterol level and significant increases in blood levels of total cholesterol, LDL-cholesterol, and triglycerides. These observations suggest that, as captopril, the extract of <italic>A. digitata</italic> mitigated the development of L-NAME-induced hypertension in rats.</p><p>Moreover, treatment with either <italic>A. digitata</italic> extract or captopril also prevented hypertension-associated affections of organs typically observed in L-NAME-induced hypertensive animals, including kidney affection as indicated by the prevention of increases in creatinine and serum urea [<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>] and liver affection, as indicated by the mitigation of the elevation of transaminase activity in the blood [<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>]. In addition, hypertension can lead to abnormalities in cardiac structure [<xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>] and dysfunction in cardiac electrical activity [<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>]. In this study, a significant increase in the relative weight of the left ventricle was observed in L-NAME-induced hypertensive control rats, but not in animals concomitantly treated with either captopril or the extract of <italic>A. digitata</italic>, further suggesting that <italic>A. digitata</italic> stem bark has antihypertensive properties. On the same hand, unlike in animals concomitantly treated with either captopril or the extract, increases in the magnitude of the QRS complex and in the duration of the QT and QRS intervals were observed in hypertensive control rats. In a previous report, L-NAME-treated rats displayed increases in RR interval and in the duration of the P wave, as well as an elevation in ST-segment, resulting in bradycardia [<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>]. Our findings are in agreement with this report, as prolongation of QT interval may indicate ventricular arrhythmia and QRS interval lengthening a slowing down of the frequency of heart contractions [<xref rid="B44" ref-type="bibr">44</xref>&#x02013;<xref rid="B46" ref-type="bibr">46</xref>].</p><p>The histopathological findings confirmed the biochemical and the electrophysiological observations. Histopathological changes typically observed in L-NAME-induced hypertensive rats, such as increased monocyte and platelet adhesion, thickening of the vascular wall, aggregation of inflammatory cells in organs [<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>], were less marked or absent in animals treated with either <italic>A. digitata</italic> extract or captopril. Altogether, these findings suggest that <italic>A. digitata</italic> extract has antihypertensive properties in L-NAME-induced hypertensive rats.</p><p>The mitigation of decreases in releases of endothelial NO observed following treatment with <italic>A. digitata</italic> in this study suggests that the extract mediated its antihypertensive activity at least partly by improving NO bioavailability [<xref rid="B7" ref-type="bibr">7</xref>&#x02013;<xref rid="B10" ref-type="bibr">10</xref>]. In addition, in this study, <italic>A. digitata</italic> extract prevented hypertension-like impairment of antioxidant defenses indicated by marked decreases in nitrite levels, reduced glutathione levels, and catalase activity, and increases in levels of lipid peroxidation indicator malondialdehyde in the heart, aorta, and kidneys in hypertensive control rats [<xref rid="B49" ref-type="bibr">49</xref>&#x02013;<xref rid="B51" ref-type="bibr">51</xref>]. These observations suggest that <italic>A. digitata</italic> extract has antioxidant properties. Such properties may contribute to the antihypertensive effects of the extract, considering the pivotal role of oxidative stress in the development of hypertension in L-NAME-induced hypertensive rats [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B49" ref-type="bibr">49</xref>].</p></sec><sec id="sec5"><title>5. Conclusions</title><p>We assessed the effects of the aqueous extract of <italic>A. digitata</italic> stem bark on the development of hypertension in L-NAME-induced hypertension rat models. The extract prevented or mitigated the hypertension-like changes in hemodynamic and electrocardiographic parameters, serum lipid profile, and oxidative stress markers, as well as aorta, heart, and kidney histopathological signs. Altogether, these findings suggest the aqueous extract of stem bark <italic>A. digitata</italic> has antihypertensive and antioxidant properties, and justify its use in folk medicine against cardiovascular disorders.</p></sec></body><back><ack><title>Acknowledgments</title><p>This study was partly funded by the Faculty of Science, University of Ngaound&#x000e9;r&#x000e9;. The authors thank the Laboratory of the Medicinal Plants, Health and Galenic Formulation of the Department of Biological Sciences. The authors thank the colleagues of their institutions for proof reading the article.</p></ack><sec sec-type="data-availability"><title>Data Availability</title><p>The datasets supporting the conclusions of this article are presented in this main paper. Plant materials used in this study have been identified at the Cameroon National Herbarium where voucher specimens are deposited.</p></sec><sec><title>Ethical Approval</title><p>Research approval was obtained from the Cameroon National Ethics Committee (ref. no. FWIRB 00001954).</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that they have no conflicts of interest.</p></sec><sec sec-type="supplementary-material" id="supplementary-material-1"><title>Supplementary Materials</title><supplementary-material content-type="local-data" id="supp-1"><label>Supplementary Materials</label><caption><p>The supplementary file includes the raw data of the article.</p></caption><media xlink:href="3678469.f1.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>D.</given-names></name><name><surname>Ling</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Hypertensive nephropathy treatment by heart-protecting musk pill: a study of anti-inflammatory therapy for target organ damage of hypertension</article-title><source><italic toggle="yes">International Journal of General Medicine</italic></source><year>2011</year><volume>4</volume><fpage>131</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.2147/IJGM.S15235</pub-id><pub-id pub-id-type="other">2-s2.0-84897367642</pub-id><pub-id pub-id-type="pmid">21475627</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binda</surname><given-names>D.</given-names></name><name><surname>Nicod</surname><given-names>L.</given-names></name><name><surname>Viollon-Abadie</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Strain difference (WKY, SPRD) in the hepatic antioxidant status in rat and effect of hypertension (SHR, DOCA). Ex vivo and in vitro data</article-title><source><italic toggle="yes">Molecular and Cellular Biochemistry</italic></source><year>2001</year><volume>218</volume><issue>1/2</issue><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1023/a:1007268825721</pub-id><pub-id pub-id-type="other">2-s2.0-0035075651</pub-id><pub-id pub-id-type="pmid">11330829</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opie</surname><given-names>L. H.</given-names></name><name><surname>Seedat</surname><given-names>Y. K.</given-names></name></person-group><article-title>Hypertension in sub-Saharan African populations</article-title><source><italic toggle="yes">Circulation</italic></source><year>2005</year><volume>112</volume><issue>23</issue><fpage>3562</fpage><lpage>3568</lpage><pub-id pub-id-type="doi">10.1161/circulationaha.105.539569</pub-id><pub-id pub-id-type="other">2-s2.0-33644877289</pub-id><pub-id pub-id-type="pmid">16330697</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingue</surname><given-names>S.</given-names></name><name><surname>Ngoe</surname><given-names>C. N.</given-names></name><name><surname>Menanga</surname><given-names>A. P.</given-names></name><etal/></person-group><article-title>Prevalence and risk factors of hypertension in urban areas of Cameroon: a nationwide population-based cross-sectional study</article-title><source><italic toggle="yes">The Journal of Clinical Hypertension</italic></source><year>2015</year><volume>17</volume><issue>10</issue><fpage>819</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.1111/jch.12604</pub-id><pub-id pub-id-type="other">2-s2.0-84942835071</pub-id><pub-id pub-id-type="pmid">26140673</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baradaran</surname><given-names>A.</given-names></name><name><surname>Nasri</surname><given-names>H.</given-names></name><name><surname>Rafieian-Kopaei</surname><given-names>M.</given-names></name></person-group><article-title>Oxidative stress and hypertension: possibility of hypertension therapy with antioxidants</article-title><source><italic toggle="yes">Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences</italic></source><year>2014</year><volume>19</volume><issue>4</issue><fpage>358</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">25097610</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>N.</given-names></name><name><surname>Dabla</surname><given-names>P.</given-names></name></person-group><article-title>Oxidative stress and antioxidants in hypertension-A current review</article-title><source><italic toggle="yes">Current Hypertension Reviews</italic></source><year>2015</year><volume>11</volume><issue>2</issue><fpage>132</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.2174/1573402111666150529130922</pub-id><pub-id pub-id-type="other">2-s2.0-84939811288</pub-id><pub-id pub-id-type="pmid">26022210</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moncada</surname><given-names>S.</given-names></name><name><surname>Palmer</surname><given-names>R. M.</given-names></name><name><surname>Higgs</surname><given-names>E. A</given-names></name></person-group><article-title>Nitric oxide: physiology, pathophysiology, and pharmacology</article-title><source><italic toggle="yes">Pharmacological Reviews</italic></source><year>1991</year><volume>43</volume><issue>2</issue><fpage>109</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">1852778</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>W.</given-names></name><name><surname>Cuong</surname><given-names>T. D.</given-names></name><name><surname>Lee</surname><given-names>J. H.</given-names></name><etal/></person-group><article-title>Arginase inhibition by ethylacetate extract ofCaesalpinia sappanLignum contributes to activation of endothelial nitric oxide synthase</article-title><source><italic toggle="yes">The Korean Journal of Physiology and Pharmacology</italic></source><year>2011</year><volume>15</volume><issue>3</issue><fpage>123</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.4196/kjpp.2011.15.3.123</pub-id><pub-id pub-id-type="other">2-s2.0-79960621595</pub-id><pub-id pub-id-type="pmid">21860589</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="book"><collab>World Health Organization</collab><source><italic toggle="yes">A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis</italic></source><year>2013</year><publisher-loc>Geneva, Switzerland</publisher-loc><publisher-name>World Health Day</publisher-name></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zafar</surname><given-names>K.</given-names></name><name><surname>Mushtaq</surname><given-names>A.</given-names></name></person-group><article-title>Assessing the primary causes of hypertension in Khyber Pakhtunkhunwa, Pakistan</article-title><source><italic toggle="yes">Journal of Biology and Life Science</italic></source><year>2015</year><volume>6</volume><fpage>24</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.5296/jbls.v6i2.7119</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamatou</surname><given-names>G. P. P.</given-names></name><name><surname>Vermaak</surname><given-names>I.</given-names></name><name><surname>Viljoen</surname><given-names>A. M.</given-names></name></person-group><article-title>An updated review of <italic>Adansonia digitata</italic>: a commercially important African tree</article-title><source><italic toggle="yes">South African Journal of Botany</italic></source><year>2011</year><volume>77</volume><issue>4</issue><fpage>908</fpage><lpage>919</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2011.08.010</pub-id><pub-id pub-id-type="other">2-s2.0-81255149535</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahima</surname><given-names>C.</given-names></name><name><surname>Didier</surname><given-names>M.</given-names></name><name><surname>Max</surname><given-names>R.</given-names></name><name><surname>Pascal</surname><given-names>D.</given-names></name><name><surname>Benjamin</surname><given-names>Y.</given-names></name><name><surname>Renaud</surname><given-names>B.</given-names></name></person-group><article-title>Biochemical and nutritional properties of baobab pulp from endemic species of Madagascar and the African mainland</article-title><source><italic toggle="yes">African Journal of Agricultural Research</italic></source><year>2013</year><volume>8</volume><issue>47</issue><fpage>6046</fpage><lpage>6054</lpage></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X. N.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Profiling hydroxycinnamic acid glycosides, iridoid glycosides, and phenylethanoid glycosides in baobab fruit pulp (<italic>Adansonia digitata</italic>)</article-title><source><italic toggle="yes">Food Research International</italic></source><year>2017</year><volume>99</volume><fpage>755</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2017.06.025</pub-id><pub-id pub-id-type="other">2-s2.0-85021328115</pub-id><pub-id pub-id-type="pmid">28784541</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammad</surname><given-names>Y. G.</given-names></name><name><surname>Hauwa&#x02019;u</surname><given-names>Y. B.</given-names></name></person-group><article-title>Hypoglycemic activity of methanolic fruit pulp extract of <italic>A. digitata</italic> on blood glucose levels of alloxan induced diabetic rats</article-title><source><italic toggle="yes">International Journal of Animal and Veterinary Advances</italic></source><year>2013</year><volume>5</volume><issue>3</issue><fpage>108</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.19026/ijava.5.5585</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahul</surname><given-names>J.</given-names></name><name><surname>Jain</surname><given-names>M. K.</given-names></name><name><surname>Singh</surname><given-names>S. P.</given-names></name><name><surname>Kamal</surname><given-names>R. K.</given-names></name><name><surname>Anuradha</surname><given-names>N.</given-names></name><name><surname>Mrityunjay</surname><given-names>S. K.</given-names></name></person-group><article-title>
<italic>Adansonia digitata</italic> L. (baobab): a review of traditional information and taxonomic description</article-title><source><italic toggle="yes">Asian Pacific Journal of Tropical Biomedicine</italic></source><year>2015</year><volume>5</volume><issue>1</issue><fpage>79</fpage><lpage>84</lpage></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Caluw&#x000e9;</surname><given-names>E.</given-names></name><name><surname>Halamov&#x000e1;</surname><given-names>K.</given-names></name><name><surname>Van Damme</surname><given-names>P.</given-names></name></person-group><article-title>
<italic>Adansonia digitata</italic> L.-a review of traditional uses. Phytochemistry Pharmacology</article-title><source><italic toggle="yes">Afrika Focus</italic></source><year>2010</year><volume>23</volume><fpage>11</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.21825/af.v23i1.5037</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adeoye</surname><given-names>A. O.</given-names></name><name><surname>Bewaji</surname><given-names>C. O.</given-names></name></person-group><article-title>Chemopreventive and remediation effect of <italic>Adansonia digitata</italic> L . Baobab (Bombacaceae) stem bark extracts in mouse model malaria</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2018</year><volume>210</volume><fpage>31</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2017.08.025</pub-id><pub-id pub-id-type="other">2-s2.0-85028499356</pub-id><pub-id pub-id-type="pmid">28843893</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shehu</surname><given-names>A.</given-names></name><name><surname>Magaji</surname><given-names>M. G.</given-names></name><name><surname>Yau</surname><given-names>J.</given-names></name><name><surname>Abubakar</surname><given-names>A.</given-names></name></person-group><article-title>Ethnobotanical survey of medicinal plants used for the management of depression by Hausa tribes of Kaduna state, Nigeria</article-title><source><italic toggle="yes">Journal of Medicinal Plants Research</italic></source><year>2017</year><volume>11</volume><fpage>562</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.5897/jmpr2017.6462</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shehu</surname><given-names>A.</given-names></name><name><surname>Magaji</surname><given-names>M. G.</given-names></name><name><surname>Magaji</surname><given-names>M.</given-names></name><name><surname>Mahmud</surname><given-names>B.</given-names></name><name><surname>Ahmed</surname><given-names>A.</given-names></name></person-group><article-title>Antidepressant effect of methanol stem bark extract of <italic>Adansonia digitata</italic> L. (Malvaceae) in mice</article-title><source><italic toggle="yes">Tropical Journal of Natural Product Research</italic></source><year>2018</year><volume>2</volume><issue>2</issue><fpage>87</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.26538/tjnpr/v2i2.6</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmoud</surname><given-names>E. K.</given-names></name><name><surname>Ghoneim</surname><given-names>A. M.</given-names></name></person-group><article-title>Effect of polluted water on soil and plant contamination by heavy metals in El-Mahla El-Kobra, Egypt</article-title><source><italic toggle="yes">Solid Earth</italic></source><year>2016</year><volume>7</volume><issue>2</issue><fpage>703</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.5194/se-7-703-2016</pub-id><pub-id pub-id-type="other">2-s2.0-84966356308</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alhassan</surname><given-names>A. J.</given-names></name><name><surname>Muhammad</surname><given-names>I. U.</given-names></name><name><surname>Jarumi</surname><given-names>A. M.</given-names></name><name><surname>Wudil</surname><given-names>A. M.</given-names></name></person-group><article-title>Evaluation of anti-hyperlipidemic potentials of aqueous fruit pulp extract of <italic>adensonia digitata</italic> in experimental rats</article-title><source><italic toggle="yes">European Scientific Journal</italic></source><year>2016</year><volume>12</volume><issue>12</issue><fpage>p. 298</fpage><pub-id pub-id-type="doi">10.19044/esj.2016.v12n12p298</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartels</surname><given-names>H.</given-names></name><name><surname>B&#x000f6;hmer</surname><given-names>M.</given-names></name><name><surname>Heierli</surname><given-names>C.</given-names></name></person-group><article-title>Serum kreatininbestimmung ohne enteiweissen</article-title><source><italic toggle="yes">Clinica Chimica Acta</italic></source><year>1972</year><volume>37</volume><fpage>193</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/0009-8981(72)90432-9</pub-id><pub-id pub-id-type="other">2-s2.0-0015305121</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gornall</surname><given-names>A. G.</given-names></name><name><surname>Bradwill</surname><given-names>C. J.</given-names></name><name><surname>David</surname><given-names>M. M.</given-names></name></person-group><article-title>Determination of serum proteins by the mean of the biuret reactions</article-title><source><italic toggle="yes">Journal of Biological Chemistry</italic></source><year>1949</year><volume>177</volume><fpage>751</fpage><lpage>766</lpage><pub-id pub-id-type="pmid">18110453</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reitman</surname><given-names>S.</given-names></name><name><surname>Frankel</surname><given-names>S.</given-names></name></person-group><article-title>A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases</article-title><source><italic toggle="yes">American Journal of Clinical Pathology</italic></source><year>1957</year><volume>28</volume><issue>1</issue><fpage>56</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1093/ajcp/28.1.56</pub-id><pub-id pub-id-type="other">2-s2.0-66349129125</pub-id><pub-id pub-id-type="pmid">13458125</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakayashi</surname><given-names>I.</given-names></name><name><surname>Kobaba</surname><given-names>W. R.</given-names></name></person-group><article-title>Effet de l&#x02019;&#x000e2;ge sur le rapport entre le boire et les rapports arth&#x000e9;roscl&#x000e9;rotiques</article-title><source><italic toggle="yes">Gerontology</italic></source><year>2002</year><volume>48</volume><fpage>151</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">11961368</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellman</surname><given-names>G. L.</given-names></name></person-group><article-title>Tissue sulfhydryl groups</article-title><source><italic toggle="yes">Archives of Biochemistry and Biophysics</italic></source><year>1959</year><volume>82</volume><issue>1</issue><fpage>70</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(59)90090-6</pub-id><pub-id pub-id-type="other">2-s2.0-3042934967</pub-id><pub-id pub-id-type="pmid">13650640</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>A. K.</given-names></name></person-group><article-title>Colorimetric assay of catalase</article-title><source><italic toggle="yes">Analytical Biochemistry</italic></source><year>1972</year><volume>47</volume><issue>2</issue><fpage>389</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(72)90132-7</pub-id><pub-id pub-id-type="other">2-s2.0-0015353270</pub-id><pub-id pub-id-type="pmid">4556490</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Slack</surname><given-names>P. T.</given-names></name></person-group><source><italic toggle="yes">Analytical Methods Manual</italic></source><year>1987</year><edition>2nd</edition><publisher-loc>British, UK</publisher-loc><publisher-name>British Food Manufacturing Industries Research Association</publisher-name><fpage>1</fpage><lpage>4</lpage></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilbur</surname><given-names>K. M.</given-names></name><name><surname>Bernheim</surname><given-names>F.</given-names></name><name><surname>Shapiro</surname><given-names>O. W.</given-names></name></person-group><article-title>Determination of lipid peroxidation</article-title><source><italic toggle="yes">Archives of Biochemistry and Biophysics</italic></source><year>1949</year><volume>24</volume><fpage>305</fpage><lpage>310</lpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilanda</surname><given-names>D. C.</given-names></name><name><surname>Dimo</surname><given-names>T.</given-names></name><name><surname>Dzeufiet Djomeni</surname><given-names>P. D.</given-names></name><etal/></person-group><article-title>Antihypertensive and antioxidant effects of Allanblackia floribunda Oliv. (Clusiaceae) aqueous extract in alcohol- and sucrose-induced hypertensive rats</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2010</year><volume>128</volume><issue>3</issue><fpage>634</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2010.02.025</pub-id><pub-id pub-id-type="other">2-s2.0-77951206329</pub-id><pub-id pub-id-type="pmid">20193752</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czech</surname><given-names>D. A.</given-names></name><name><surname>Kazel</surname><given-names>M. R.</given-names></name><name><surname>Harris</surname><given-names>J.</given-names></name></person-group><article-title>A nitric oxide synthase inhibitor, NG-nitro-l-arginine methyl ester, attenuates lipoprivic feeding in mice</article-title><source><italic toggle="yes">Physiology &#x00026; Behavior</italic></source><year>2003</year><volume>80</volume><issue>1</issue><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/s0031-9384(03)00220-8</pub-id><pub-id pub-id-type="other">2-s2.0-0141887631</pub-id><pub-id pub-id-type="pmid">14568310</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farr</surname><given-names>S. A.</given-names></name><name><surname>Banks</surname><given-names>W. A.</given-names></name><name><surname>Kumar</surname><given-names>V. B.</given-names></name><name><surname>Morley</surname><given-names>J. E.</given-names></name></person-group><article-title>Orexin-A-induced feeding is dependent on nitric oxide</article-title><source><italic toggle="yes">Peptides</italic></source><year>2005</year><volume>26</volume><issue>5</issue><fpage>759</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.1016/j.peptides.2004.12.004</pub-id><pub-id pub-id-type="other">2-s2.0-16244394062</pub-id><pub-id pub-id-type="pmid">15808906</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saravanakumar</surname><given-names>M.</given-names></name><name><surname>Raja</surname><given-names>B.</given-names></name></person-group><article-title>Effect of veratric acid on the cardiovascular risk of L-NAME-induced hypertensive rats</article-title><source><italic toggle="yes">Journal of Cardiovascular Pharmacology</italic></source><year>2012</year><volume>59</volume><issue>6</issue><fpage>553</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1097/fjc.0b013e31824f9174</pub-id><pub-id pub-id-type="other">2-s2.0-84862190068</pub-id><pub-id pub-id-type="pmid">22361750</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsague</surname><given-names>M. V.</given-names></name><name><surname>Fokunang</surname><given-names>N. C.</given-names></name><name><surname>Tembe</surname><given-names>A. E.</given-names></name><etal/></person-group><article-title>Hydroethanolic extract of <italic>Eribroma oblongum</italic> (malvaceae) stem bark</article-title><source><italic toggle="yes">Journal of Diseases and Medicinal Plants</italic></source><year>2016</year><volume>2</volume><issue>4</issue><fpage>43</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.11648/j.jdmp.20160206.13</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lameire</surname><given-names>N.</given-names></name><name><surname>Vanbiesen</surname><given-names>W.</given-names></name><name><surname>Vanholder</surname><given-names>R.</given-names></name></person-group><article-title>Acute renal failure</article-title><source><italic toggle="yes">The Lancet</italic></source><year>2005</year><volume>365</volume><issue>9457</issue><fpage>417</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1016/s0140-6736(05)70238-5</pub-id><pub-id pub-id-type="other">2-s2.0-13144267730</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>K.</given-names></name><name><surname>Tomita</surname><given-names>S.</given-names></name><name><surname>Ishizawa</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Dietary nitrite ameliorates renal injury in L-NAME-induced hypertensive rats</article-title><source><italic toggle="yes">Nitric Oxide</italic></source><year>2010</year><volume>22</volume><issue>2</issue><fpage>98</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.niox.2009.12.002</pub-id><pub-id pub-id-type="other">2-s2.0-75149195196</pub-id><pub-id pub-id-type="pmid">20005970</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prahalathan</surname><given-names>P.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Raja</surname><given-names>B.</given-names></name></person-group><article-title>Effect of morin, a flavonoid against DOCA-salt hypertensive rats: a dose dependent study</article-title><source><italic toggle="yes">Asian Pacific Journal of Tropical Biomedicine</italic></source><year>2012</year><volume>2</volume><issue>6</issue><fpage>443</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1016/s2221-1691(12)60073-2</pub-id><pub-id pub-id-type="pmid">23569947</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Acute and subacute toxicity of ethanol extracts from Salvia przewalskii Maxim in rodents</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2010</year><volume>131</volume><issue>1</issue><fpage>110</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2010.06.012</pub-id><pub-id pub-id-type="other">2-s2.0-77955311022</pub-id><pub-id pub-id-type="pmid">20561576</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miguel-Carrasco</surname><given-names>J. L.</given-names></name><name><surname>Monserrat</surname><given-names>M. T.</given-names></name><name><surname>Mate</surname><given-names>A.</given-names></name><name><surname>V&#x000e1;zquez</surname><given-names>C. M.</given-names></name></person-group><article-title>Comparative effects of captopril and L-carnitine on blood pressure and antioxidant enzyme gene expression in the heart of spontaneously hypertensive rats</article-title><source><italic toggle="yes">European Journal of Pharmacology</italic></source><year>2010</year><volume>632</volume><issue>1&#x02013;3</issue><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2010.01.017</pub-id><pub-id pub-id-type="other">2-s2.0-77349090650</pub-id><pub-id pub-id-type="pmid">20123095</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuspidi</surname><given-names>C.</given-names></name><name><surname>Rescaldani</surname><given-names>M.</given-names></name><name><surname>Sala</surname><given-names>C.</given-names></name><name><surname>Negri</surname><given-names>F.</given-names></name><name><surname>Grassi</surname><given-names>G.</given-names></name><name><surname>Mancia</surname><given-names>G.</given-names></name></person-group><article-title>Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension</article-title><source><italic toggle="yes">Journal of Hypertension</italic></source><year>2012</year><volume>30</volume><issue>11</issue><fpage>2066</fpage><lpage>2073</lpage><pub-id pub-id-type="doi">10.1097/hjh.0b013e32835726a3</pub-id><pub-id pub-id-type="other">2-s2.0-84867745191</pub-id><pub-id pub-id-type="pmid">22914541</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozos</surname><given-names>I.</given-names></name><name><surname>Caraba</surname><given-names>A.</given-names></name></person-group><article-title>Electrocardiographic predictors of cardiovascular mortality</article-title><source><italic toggle="yes">Disease Markers</italic></source><year>2015</year><volume>72</volume><fpage>10</fpage><pub-id pub-id-type="publisher-id">727401</pub-id><pub-id pub-id-type="doi">10.1155/2015/727401</pub-id><pub-id pub-id-type="other">2-s2.0-84938232870</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansur</surname><given-names>P. H.</given-names></name><name><surname>Cury</surname><given-names>L. K.</given-names></name><name><surname>Destro-Filho</surname><given-names>J. B.</given-names></name><etal/></person-group><article-title>Analysis of electrocardiographic recordings associated with acute myocardial infarction</article-title><source><italic toggle="yes">Arquivos Brasileiros de Cardiologia</italic></source><year>2006</year><volume>87</volume><issue>2</issue><fpage>106</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1590/s0066-782x2006001500007</pub-id><pub-id pub-id-type="pmid">16951827</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Mosallamy</surname><given-names>A. E. M. K.</given-names></name><name><surname>Sleem</surname><given-names>A. A.</given-names></name><name><surname>Abdel-Salam</surname><given-names>O. M. E.</given-names></name><name><surname>Shaffie</surname><given-names>N.</given-names></name><name><surname>Kenawy</surname><given-names>S. A.</given-names></name></person-group><article-title>Antihypertensive and cardioprotective effects of pumpkin seed oil</article-title><source><italic toggle="yes">Journal of Medicinal Food</italic></source><year>2012</year><volume>15</volume><issue>2</issue><fpage>180</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1089/jmf.2010.0299</pub-id><pub-id pub-id-type="other">2-s2.0-84856243790</pub-id><pub-id pub-id-type="pmid">22082068</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname><given-names>J.</given-names></name><name><surname>Goldwasser</surname><given-names>G. P.</given-names></name></person-group><article-title>Electrocardiogram: recommendations for interpretation</article-title><source><italic toggle="yes">Chemical Society Reviews</italic></source><year>2004</year><volume>17</volume><issue>4</issue><fpage>251</fpage><lpage>256</lpage></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verweij</surname><given-names>N.</given-names></name><name><surname>Leach</surname><given-names>I. M.</given-names></name><name><surname>van den Boogaard</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Genetic determinants of P wave duration and PR segment</article-title><source><italic toggle="yes">Circulation: Cardiovascular Genetics</italic></source><year>2014</year><volume>7</volume><issue>4</issue><fpage>475</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1161/circgenetics.113.000373</pub-id><pub-id pub-id-type="other">2-s2.0-84925970717</pub-id><pub-id pub-id-type="pmid">24850809</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjerregaard</surname><given-names>P.</given-names></name><name><surname>Nallapaneni</surname><given-names>H.</given-names></name><name><surname>Gussak</surname><given-names>I.</given-names></name></person-group><article-title>Short QT interval in clinical practice</article-title><source><italic toggle="yes">Journal of Electrocardiology</italic></source><year>2010</year><volume>43</volume><issue>5</issue><fpage>390</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1016/j.jelectrocard.2010.06.004</pub-id><pub-id pub-id-type="other">2-s2.0-79952117663</pub-id><pub-id pub-id-type="pmid">20667544</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolores</surname><given-names>P. M.</given-names></name><name><surname>Paola</surname><given-names>R.</given-names></name><name><surname>Noem&#x000ed;</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Beneficial effects of different flavonoids on vascular and renal function in LN hypertensive rats</article-title><source><italic toggle="yes">Nutrients</italic></source><year>2018</year><volume>8</volume><issue>10</issue><fpage>p. 484</fpage><pub-id pub-id-type="doi">10.3390/nu10040484</pub-id><pub-id pub-id-type="other">2-s2.0-85045651821</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida Rezende</surname><given-names>B.</given-names></name><name><surname>Pereira</surname><given-names>A. C.</given-names></name><name><surname>Cortes</surname><given-names>S. F.</given-names></name><name><surname>Lemos</surname><given-names>V. S.</given-names></name></person-group><article-title>Vascular effects of flavonoids</article-title><source><italic toggle="yes">Current Medicinal Chemistry</italic></source><year>2016</year><volume>23</volume><fpage>87</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">26555950</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigo</surname><given-names>R.</given-names></name><name><surname>Prat</surname><given-names>H.</given-names></name><name><surname>Passalacqua</surname><given-names>W.</given-names></name><name><surname>Araya</surname><given-names>J.</given-names></name><name><surname>Guichard</surname><given-names>C.</given-names></name><name><surname>B&#x000e4;chler</surname><given-names>J. P.</given-names></name></person-group><article-title>Relationship between oxidative stress and essential hypertension</article-title><source><italic toggle="yes">Hypertension Research</italic></source><year>2007</year><volume>30</volume><issue>12</issue><fpage>1159</fpage><lpage>1167</lpage><pub-id pub-id-type="doi">10.1291/hypres.30.1159</pub-id><pub-id pub-id-type="other">2-s2.0-38749104742</pub-id><pub-id pub-id-type="pmid">18344620</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nayeemunisa</surname></name><name><surname>Kumda</surname><given-names>M. R.</given-names></name></person-group><article-title>Cardioprotective effects of <italic>Cichorium intybus</italic> in ageing myocardium of albino rats</article-title><source><italic toggle="yes">Current Science</italic></source><year>2003</year><volume>84</volume><fpage>94</fpage><lpage>943</lpage></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>A.</given-names></name><name><surname>Singhal</surname><given-names>U.</given-names></name><name><surname>Hossain</surname><given-names>M. M.</given-names></name><name><surname>Islam</surname><given-names>N.</given-names></name><name><surname>Rizvi</surname><given-names>I.</given-names></name></person-group><article-title>The role of the endogenous antioxidant enzymes and malondialdehyde in essential hypertension</article-title><source><italic toggle="yes">Journal of Clinical and Diagnostic Research</italic></source><year>2013</year><volume>7</volume><fpage>987</fpage><lpage>990</lpage><pub-id pub-id-type="doi">10.7860/jcdr/2013/5829.3091</pub-id><pub-id pub-id-type="other">2-s2.0-84878867846</pub-id><pub-id pub-id-type="pmid">23905086</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Oxidative stress indicators. Effects of the aqueous extract of <italic>Adansonia digitata</italic> on aorta, heart, and kidney levels or activities of (a) nitrite, (b) malondialdehyde, (c) catalase, and (d) reduced glutathione.</p></caption><graphic xlink:href="ECAM2020-3678469.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Aorta, heart, and kidney histopathology.</p></caption><graphic xlink:href="ECAM2020-3678469.002"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Body, heart, and kidneys weights after 3 weeks of treatment.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Parameters</th><th align="center" rowspan="1" colspan="1">Normotensive control</th><th align="center" rowspan="1" colspan="1">Hypertensive ctrl</th><th align="center" rowspan="1" colspan="1">LN&#x02009;+&#x02009;captopril</th><th align="center" rowspan="1" colspan="1">LN&#x02009;+&#x02009;AD100</th><th align="center" rowspan="1" colspan="1">LN&#x02009;+&#x02009;AD200</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Body weight week 3 (g)</td><td align="center" rowspan="1" colspan="1">229.95&#x02009;&#x000b1;&#x02009;2.02</td><td align="center" rowspan="1" colspan="1">209.37&#x02009;&#x000b1;&#x02009;0.80<sup>c</sup></td><td align="center" rowspan="1" colspan="1">219.10&#x02009;&#x000b1;&#x02009;1.68<sup><italic>&#x003b4;</italic></sup></td><td align="center" rowspan="1" colspan="1">206.50&#x02009;&#x000b1;&#x02009;1.38</td><td align="center" rowspan="1" colspan="1">216.35&#x02009;&#x000b1;&#x02009;0.77<sup><italic>&#x003b4;</italic></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Body W gain (% baseline)</td><td align="center" rowspan="1" colspan="1">26.11&#x02009;&#x000b1;&#x02009;2.91</td><td align="center" rowspan="1" colspan="1">11.77&#x02009;&#x000b1;&#x02009;3.48<sup>a</sup></td><td align="center" rowspan="1" colspan="1">12.79&#x02009;&#x000b1;&#x02009;1.79</td><td align="center" rowspan="1" colspan="1">22.85&#x02009;&#x000b1;&#x02009;1.55<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">14.95&#x02009;&#x000b1;&#x02009;6.97<sup><italic>&#x003b4;</italic></sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Kidney W (g/100&#x02009;g BW)</td><td align="center" rowspan="1" colspan="1">0.59&#x02009;&#x000b1;&#x02009;0.05</td><td align="center" rowspan="1" colspan="1">0.79&#x02009;&#x000b1;&#x02009;0.05<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.60&#x02009;&#x000b1;&#x02009;0.01<sup><italic>&#x003b4;</italic></sup></td><td align="center" rowspan="1" colspan="1">0.56&#x02009;&#x000b1;&#x02009;0.01<sup><italic>&#x003b4;</italic></sup></td><td align="center" rowspan="1" colspan="1">0.61&#x02009;&#x000b1;&#x02009;0.01<sup><italic>&#x003b4;</italic></sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Heart W (g/100&#x02009;g BW)</td><td align="center" rowspan="1" colspan="1">0.32&#x02009;&#x000b1;&#x02009;0.02</td><td align="center" rowspan="1" colspan="1">0.37&#x02009;&#x000b1;&#x02009;0.02<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.31&#x02009;&#x000b1;&#x02009;0.03<sup><italic>&#x003b4;</italic></sup></td><td align="center" rowspan="1" colspan="1">0.29&#x02009;&#x000b1;&#x02009;0.01<sup><italic>&#x003b2;</italic></sup></td><td align="center" rowspan="1" colspan="1">0.34&#x02009;&#x000b1;&#x02009;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Left ventricle W (g/100&#x02009;g)</td><td align="center" rowspan="1" colspan="1">0.13&#x02009;&#x000b1;&#x02009;0.01</td><td align="center" rowspan="1" colspan="1">0.18&#x02009;&#x000b1;&#x02009;0.01<sup>a</sup></td><td align="center" rowspan="1" colspan="1">0.16&#x02009;&#x000b1;&#x02009;0.01</td><td align="center" rowspan="1" colspan="1">0.14&#x02009;&#x000b1;&#x02009;0.01<sup><italic>&#x003b4;</italic></sup></td><td align="center" rowspan="1" colspan="1">0.16&#x02009;&#x000b1;&#x02009;0.01</td></tr></tbody></table><table-wrap-foot><fn><p>Data are mean&#x02009;&#x000b1;&#x02009;SEM (<italic>N</italic>&#x02009;=&#x02009;6 per group). ANOVA&#x02009;+&#x02009;the Tukey test: <sup>c</sup><italic>p</italic> &#x0003c; 0.05 and <sup>a</sup><italic>p</italic> &#x0003c; 0.001 vs. the normotensive control group; <sup><italic>&#x003b4;</italic></sup><italic>p</italic> &#x0003c; 0.05, <sup><italic>&#x003b2;</italic></sup><italic>p</italic> &#x0003c; 0.01, and <sup><italic>&#x003b1;</italic></sup><italic>p</italic> &#x0003c; 0.001 vs. the hypertensive control group. AD100/AD200&#x02009;=&#x02009;extract doses 100 or 200&#x02009;mg/kg. LN&#x02009;=&#x02009;N-NAME.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Effects of <italic>A. digitata</italic> extract on blood pressure and heart rate of hypertensive rats.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="center" rowspan="1" colspan="1">SBP (mm Hg)</th><th align="center" rowspan="1" colspan="1">DBP (mm Hg)</th><th align="center" rowspan="1" colspan="1">MABP (mm Hg)</th><th align="center" rowspan="1" colspan="1">HR (BPM)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Normotensive control</td><td align="center" rowspan="1" colspan="1">113.24&#x02009;&#x000b1;&#x02009;2.85</td><td align="center" rowspan="1" colspan="1">81.63&#x02009;&#x000b1;&#x02009;3.26</td><td align="center" rowspan="1" colspan="1">92.17&#x02009;&#x000b1;&#x02009;3.11</td><td align="center" rowspan="1" colspan="1">345.61&#x02009;&#x000b1;&#x02009;4.65</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertensive control</td><td align="center" rowspan="1" colspan="1">189.49&#x02009;&#x000b1;&#x02009;3.85<sup>a</sup></td><td align="center" rowspan="1" colspan="1">147.26&#x02009;&#x000b1;&#x02009;5.40<sup>a</sup></td><td align="center" rowspan="1" colspan="1">161.34&#x02009;&#x000b1;&#x02009;4.79<sup>a</sup></td><td align="center" rowspan="1" colspan="1">390.28&#x02009;&#x000b1;&#x02009;16.45<sup>c</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">LN&#x02009;+&#x02009;captopril</td><td align="center" rowspan="1" colspan="1">147.18&#x02009;&#x000b1;&#x02009;5.82<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">118.65&#x02009;&#x000b1;&#x02009;5.35<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">128.16&#x02009;&#x000b1;&#x02009;5.32<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">349.98&#x02009;&#x000b1;&#x02009;8.27</td></tr><tr><td align="left" rowspan="1" colspan="1">LN&#x02009;+&#x02009;AD100</td><td align="center" rowspan="1" colspan="1">172.64&#x02009;&#x000b1;&#x02009;1.61<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">135.77&#x02009;&#x000b1;&#x02009;1.50<sup><italic>&#x003b2;</italic></sup></td><td align="center" rowspan="1" colspan="1">148.06&#x02009;&#x000b1;&#x02009;1.40<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">349.48&#x02009;&#x000b1;&#x02009;13.16</td></tr><tr><td align="left" rowspan="1" colspan="1">LN&#x02009;+&#x02009;AD200</td><td align="center" rowspan="1" colspan="1">149.07&#x02009;&#x000b1;&#x02009;7.86<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">115.10&#x02009;&#x000b1;&#x02009;6.73<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">126.42&#x02009;&#x000b1;&#x02009;7.08<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">341.04&#x02009;&#x000b1;&#x02009;19.20<sup><italic>&#x003b1;</italic></sup></td></tr></tbody></table><table-wrap-foot><fn><p>Data are mean&#x02009;&#x000b1;&#x02009;SEM (<italic>N</italic>&#x02009;=&#x02009;6 per group). ANOVA&#x02009;+&#x02009;the Tukey test: <sup>c</sup><italic>p</italic> &#x0003c; 0.05 and <sup>a</sup><italic>p</italic> &#x0003c; 0.001 vs. the normotensive control group; <sup><italic>&#x003b4;</italic></sup><italic>p</italic> &#x0003c; 0.05, <sup><italic>&#x003b2;</italic></sup><italic>p</italic> &#x0003c; 0.01, and <sup><italic>&#x003b1;</italic></sup><italic>p</italic> &#x0003c; 0.001 vs. the hypertensive control group. AD100/AD200&#x02009;=&#x02009;extract doses 100 or 200&#x02009;mg/kg. DBP&#x02009;=&#x02009;diastolic arterial blood pressure. HR&#x02009;=&#x02009;heart rate. LN&#x02009;=&#x02009;N-NAME. MABP&#x02009;=&#x02009;mean arterial blood pressure. SBP&#x02009;=&#x02009;systolic arterial blood pressure.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Effects of <italic>A. digitata</italic> extract on the electrocardiogram of hypertensive rats.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">ECG Parameter</th><th align="center" colspan="6" rowspan="1">Time (ms)</th><th align="center" colspan="2" rowspan="1">Magnitude (mV)</th></tr><tr><th align="center" rowspan="1" colspan="1">P-R Int</th><th align="center" rowspan="1" colspan="1">QRS Int</th><th align="center" rowspan="1" colspan="1">Q-T Int</th><th align="center" rowspan="1" colspan="1">S-T Int</th><th align="center" rowspan="1" colspan="1">S-T Seg</th><th align="center" rowspan="1" colspan="1">R-R Int</th><th align="center" rowspan="1" colspan="1">P wave</th><th align="center" rowspan="1" colspan="1">QRS complex</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Normotensive ctrl</td><td align="center" rowspan="1" colspan="1">43.3&#x02009;&#x000b1;&#x02009;0.3</td><td align="center" rowspan="1" colspan="1">22.0&#x02009;&#x000b1;&#x02009;1.0</td><td align="center" rowspan="1" colspan="1">66.0&#x02009;&#x000b1;&#x02009;3.9</td><td align="center" rowspan="1" colspan="1">35.0&#x02009;&#x000b1;&#x02009;0.5</td><td align="center" rowspan="1" colspan="1">5.0&#x02009;&#x000b1;&#x02009;0.1</td><td align="center" rowspan="1" colspan="1">148.3&#x02009;&#x000b1;&#x02009;0.4</td><td align="center" rowspan="1" colspan="1">0.09&#x02009;&#x000b1;&#x02009;0.01</td><td align="center" rowspan="1" colspan="1">0.58&#x02009;&#x000b1;&#x02009;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertensive ctrl</td><td align="center" rowspan="1" colspan="1">42.7&#x02009;&#x000b1;&#x02009;0.6</td><td align="center" rowspan="1" colspan="1">37.7&#x02009;&#x000b1;&#x02009;0.6<sup>c</sup></td><td align="center" rowspan="1" colspan="1">85.7&#x02009;&#x000b1;&#x02009;0.6<sup>b</sup></td><td align="center" rowspan="1" colspan="1">39.3&#x02009;&#x000b1;&#x02009;0.3</td><td align="center" rowspan="1" colspan="1">8.7&#x02009;&#x000b1;&#x02009;0.3</td><td align="center" rowspan="1" colspan="1">159.3&#x02009;&#x000b1;&#x02009;0.3</td><td align="center" rowspan="1" colspan="1">0.08&#x02009;&#x000b1;&#x02009;0.01</td><td align="center" rowspan="1" colspan="1">0.61&#x02009;&#x000b1;&#x02009;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">LN&#x02009;+&#x02009;captopril</td><td align="center" rowspan="1" colspan="1">45.7&#x02009;&#x000b1;&#x02009;0.3</td><td align="center" rowspan="1" colspan="1">19.7&#x02009;&#x000b1;&#x02009;0.8<sup><italic>&#x003b4;</italic></sup></td><td align="center" rowspan="1" colspan="1">62.0&#x02009;&#x000b1;&#x02009;0.3<sup><italic>&#x003b2;</italic></sup></td><td align="center" rowspan="1" colspan="1">40.3&#x02009;&#x000b1;&#x02009;1.2</td><td align="center" rowspan="1" colspan="1">7.0&#x02009;&#x000b1;&#x02009;0.5</td><td align="center" rowspan="1" colspan="1">168.8&#x02009;&#x000b1;&#x02009;0.6</td><td align="center" rowspan="1" colspan="1">0.08&#x02009;&#x000b1;&#x02009;0.01</td><td align="center" rowspan="1" colspan="1">0.48&#x02009;&#x000b1;&#x02009;0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">LN&#x02009;+&#x02009;AD100</td><td align="center" rowspan="1" colspan="1">49.3&#x02009;&#x000b1;&#x02009;0.6<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">30.3&#x02009;&#x000b1;&#x02009;0.8</td><td align="center" rowspan="1" colspan="1">65.3&#x02009;&#x000b1;&#x02009;1.0<sup><italic>&#x003b2;</italic></sup></td><td align="center" rowspan="1" colspan="1">40.3&#x02009;&#x000b1;&#x02009;0.8</td><td align="center" rowspan="1" colspan="1">6.6&#x02009;&#x000b1;&#x02009;0.3</td><td align="center" rowspan="1" colspan="1">169.7&#x02009;&#x000b1;&#x02009;0.8</td><td align="center" rowspan="1" colspan="1">0.12&#x02009;&#x000b1;&#x02009;0.01</td><td align="center" rowspan="1" colspan="1">0.73&#x02009;&#x000b1;&#x02009;0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">LN&#x02009;+&#x02009;AD200</td><td align="center" rowspan="1" colspan="1">49.3&#x02009;&#x000b1;&#x02009;0.6<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">21.0&#x02009;&#x000b1;&#x02009;0.0<sup><italic>&#x003b4;</italic></sup></td><td align="center" rowspan="1" colspan="1">65.6&#x02009;&#x000b1;&#x02009;1.5<sup><italic>&#x003b2;</italic></sup></td><td align="center" rowspan="1" colspan="1">46.0&#x02009;&#x000b1;&#x02009;0.9</td><td align="center" rowspan="1" colspan="1">7.6&#x02009;&#x000b1;&#x02009;0.3</td><td align="center" rowspan="1" colspan="1">156.0&#x02009;&#x000b1;&#x02009;1.0</td><td align="center" rowspan="1" colspan="1">0.11&#x02009;&#x000b1;&#x02009;0.01</td><td align="center" rowspan="1" colspan="1">0.43&#x02009;&#x000b1;&#x02009;0.02</td></tr></tbody></table><table-wrap-foot><fn><p>Data are mean&#x02009;&#x000b1;&#x02009;SEM (<italic>N</italic>&#x02009;=&#x02009;6 per group). ANOVA&#x02009;+&#x02009;the Tukey test: <sup>b</sup><italic>p</italic> &#x0003c; 0.01 vs. the normotensive control group; <sup><italic>&#x003b4;</italic></sup><italic>p</italic> &#x0003c; 0.05, <sup><italic>&#x003b2;</italic></sup><italic>p</italic> &#x0003c; 0.01, and <sup><italic>&#x003b1;</italic></sup><italic>p</italic> &#x0003c; 0.001 vs. the hypertensive control group. AD100/AD200&#x02009;=&#x02009;extract doses 100 or 200&#x02009;mg/kg. Int&#x02009;=&#x02009;interval. LN&#x02009;=&#x02009;N-NAME. Seg&#x02009;=&#x02009;segment.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Effects of <italic>A. digitata</italic> extract on blood lipid profile of hypertensive rats.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="center" rowspan="1" colspan="1">Normotensive control</th><th align="center" rowspan="1" colspan="1">Hypertensive ctrl</th><th align="center" rowspan="1" colspan="1">LN&#x02009;+&#x02009;captopril</th><th align="center" rowspan="1" colspan="1">LN&#x02009;+&#x02009;AD100</th><th align="center" rowspan="1" colspan="1">LN&#x02009;+&#x02009;AD200</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Total cholesterol (mg/dL)</td><td align="center" rowspan="1" colspan="1">65.24&#x02009;&#x000b1;&#x02009;1.28</td><td align="center" rowspan="1" colspan="1">80.47&#x02009;&#x000b1;&#x02009;1.61<sup>b</sup></td><td align="center" rowspan="1" colspan="1">66.02&#x02009;&#x000b1;&#x02009;1.70<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">69.90&#x02009;&#x000b1;&#x02009;2.14</td><td align="center" rowspan="1" colspan="1">59.42&#x02009;&#x000b1;&#x02009;1.85<sup><italic>&#x003b4;</italic></sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Triglycerides (mg/dL)</td><td align="center" rowspan="1" colspan="1">33.29&#x02009;&#x000b1;&#x02009;1.57</td><td align="center" rowspan="1" colspan="1">51.07&#x02009;&#x000b1;&#x02009;0.86<sup>c</sup></td><td align="center" rowspan="1" colspan="1">28.98&#x02009;&#x000b1;&#x02009;1.58<sup><italic>&#x003b4;</italic></sup></td><td align="center" rowspan="1" colspan="1">40.82&#x02009;&#x000b1;&#x02009;6.69</td><td align="center" rowspan="1" colspan="1">37.94&#x02009;&#x000b1;&#x02009;3.26<sup><italic>&#x003b2;</italic></sup></td></tr><tr><td align="left" rowspan="1" colspan="1">HDL-cholesterol (mg/dL)</td><td align="center" rowspan="1" colspan="1">30.28&#x02009;&#x000b1;&#x02009;3.62</td><td align="center" rowspan="1" colspan="1">11.15&#x02009;&#x000b1;&#x02009;0.64<sup>b</sup></td><td align="center" rowspan="1" colspan="1">24.18&#x02009;&#x000b1;&#x02009;3.27<sup><italic>&#x003b4;</italic></sup></td><td align="center" rowspan="1" colspan="1">18.87&#x02009;&#x000b1;&#x02009;0.50</td><td align="center" rowspan="1" colspan="1">17.02&#x02009;&#x000b1;&#x02009;2.69</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL-cholesterol (mg/dL)</td><td align="center" rowspan="1" colspan="1">28.21&#x02009;&#x000b1;&#x02009;4.47</td><td align="center" rowspan="1" colspan="1">45.52&#x02009;&#x000b1;&#x02009;3.65<sup>b</sup></td><td align="center" rowspan="1" colspan="1">36.04&#x02009;&#x000b1;&#x02009;3.31</td><td align="center" rowspan="1" colspan="1">42.87&#x02009;&#x000b1;&#x02009;1.58</td><td align="center" rowspan="1" colspan="1">34.81&#x02009;&#x000b1;&#x02009;2.81</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiac risk ratio</td><td align="center" rowspan="1" colspan="1">2.15</td><td align="center" rowspan="1" colspan="1">7.22<sup>a</sup></td><td align="center" rowspan="1" colspan="1">2.73<sup><italic>&#x003b2;</italic></sup></td><td align="center" rowspan="1" colspan="1">3.70<sup><italic>&#x003b4;</italic></sup></td><td align="center" rowspan="1" colspan="1">3.49<sup><italic>&#x003b4;</italic></sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Atherogenic index</td><td align="center" rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1">0.66</td><td align="center" rowspan="1" colspan="1">0.08</td><td align="center" rowspan="1" colspan="1">0.34</td><td align="center" rowspan="1" colspan="1">0.35</td></tr></tbody></table><table-wrap-foot><fn><p>Data are mean&#x02009;&#x000b1;&#x02009;SEM (<italic>N</italic>&#x02009;=&#x02009;6 per group). ANOVA&#x02009;+&#x02009;the Tukey test: <sup>c</sup><italic>p</italic> &#x0003c; 0.05, <sup>b</sup><italic>p</italic> &#x0003c; 0.01, and <sup>a</sup><italic>p</italic> &#x0003c; 0.001 vs. the normotensive control group; <sup><italic>&#x003b4;</italic></sup><italic>p</italic> &#x0003c; 0.05, <sup><italic>&#x003b2;</italic></sup><italic>p</italic> &#x0003c; 0.01, and <sup><italic>&#x003b1;</italic></sup><italic>p</italic> &#x0003c; 0.001 vs. the hypertensive control group. AD100/AD200&#x02009;=&#x02009;extract doses 100 or 200&#x02009;mg/kg. LN&#x02009;=&#x02009;N-NAME.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Effects of <italic>A. digitata</italic> on blood indicators of liver and kidney functions in hypertensive rats.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="center" rowspan="1" colspan="1">Normotensive control</th><th align="center" rowspan="1" colspan="1">Hypertensive control</th><th align="center" rowspan="1" colspan="1">LN&#x02009;+&#x02009;captopril</th><th align="center" rowspan="1" colspan="1">LN&#x02009;+&#x02009;AD100</th><th align="center" rowspan="1" colspan="1">LN&#x02009;+&#x02009;AD200</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ASAT (UI/L)</td><td align="center" rowspan="1" colspan="1">116.7&#x02009;&#x000b1;&#x02009;6.13</td><td align="center" rowspan="1" colspan="1">179.7&#x02009;&#x000b1;&#x02009;11.52<sup>a</sup></td><td align="center" rowspan="1" colspan="1">76.5&#x02009;&#x000b1;&#x02009;7.31<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">94.8&#x02009;&#x000b1;&#x02009;9.74<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">106.6&#x02009;&#x000b1;&#x02009;7.22<sup><italic>&#x003b1;</italic></sup></td></tr><tr><td align="left" rowspan="1" colspan="1">ALAT (UI/L)</td><td align="center" rowspan="1" colspan="1">41.6&#x02009;&#x000b1;&#x02009;1.36</td><td align="center" rowspan="1" colspan="1">55.3&#x02009;&#x000b1;&#x02009;4.37<sup>b</sup></td><td align="center" rowspan="1" colspan="1">39.9&#x02009;&#x000b1;&#x02009;2.09<sup><italic>&#x003b2;</italic></sup></td><td align="center" rowspan="1" colspan="1">38.4&#x02009;&#x000b1;&#x02009;1.81<sup><italic>&#x003b2;</italic></sup></td><td align="center" rowspan="1" colspan="1">38.1&#x02009;&#x000b1;&#x02009;1.64<sup><italic>&#x003b2;</italic></sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Total protein (mg/dL)</td><td align="center" rowspan="1" colspan="1">1.3&#x02009;&#x000b1;&#x02009;0.08</td><td align="center" rowspan="1" colspan="1">2.4&#x02009;&#x000b1;&#x02009;0.11<sup>a</sup></td><td align="center" rowspan="1" colspan="1">1.8&#x02009;&#x000b1;&#x02009;0.52<sup><italic>&#x003b2;</italic></sup></td><td align="center" rowspan="1" colspan="1">1.8&#x02009;&#x000b1;&#x02009;0.05<sup><italic>&#x003b2;</italic></sup></td><td align="center" rowspan="1" colspan="1">1.8&#x02009;&#x000b1;&#x02009;0.07<sup><italic>&#x003b2;</italic></sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine (mg/dL)</td><td align="center" rowspan="1" colspan="1">4.8&#x02009;&#x000b1;&#x02009;1.68</td><td align="center" rowspan="1" colspan="1">15.6&#x02009;&#x000b1;&#x02009;1.29<sup>a</sup></td><td align="center" rowspan="1" colspan="1">4.9&#x02009;&#x000b1;&#x02009;0.28<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">6.5&#x02009;&#x000b1;&#x02009;0.28<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">3.5&#x02009;&#x000b1;&#x02009;3.12<sup><italic>&#x003b1;</italic></sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Sodium (mEq/L)</td><td align="center" rowspan="1" colspan="1">115.4&#x02009;&#x000b1;&#x02009;1.89</td><td align="center" rowspan="1" colspan="1">139.4&#x02009;&#x000b1;&#x02009;8.03<sup>b</sup></td><td align="center" rowspan="1" colspan="1">116.8&#x02009;&#x000b1;&#x02009;1.63<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">100.6&#x02009;&#x000b1;&#x02009;2.97<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">86.6&#x02009;&#x000b1;&#x02009;7.38<sup><italic>&#x003b1;</italic></sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Potassium (mEq/L)</td><td align="center" rowspan="1" colspan="1">10.9&#x02009;&#x000b1;&#x02009;0.14</td><td align="center" rowspan="1" colspan="1">6.1&#x02009;&#x000b1;&#x02009;0.06<sup>b</sup></td><td align="center" rowspan="1" colspan="1">8.8&#x02009;&#x000b1;&#x02009;0.05<sup><italic>&#x003b2;</italic></sup></td><td align="center" rowspan="1" colspan="1">11.6&#x02009;&#x000b1;&#x02009;0.36<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">15.2&#x02009;&#x000b1;&#x02009;0.59<sup><italic>&#x003b1;</italic></sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Chloride (mEq/L)</td><td align="center" rowspan="1" colspan="1">87.6&#x02009;&#x000b1;&#x02009;1.23</td><td align="center" rowspan="1" colspan="1">93.0&#x02009;&#x000b1;&#x02009;0.91<sup>c</sup></td><td align="center" rowspan="1" colspan="1">87.9&#x02009;&#x000b1;&#x02009;0.30<sup><italic>&#x003b4;</italic></sup></td><td align="center" rowspan="1" colspan="1">80.3&#x02009;&#x000b1;&#x02009;0.21<sup><italic>&#x003b1;</italic></sup></td><td align="center" rowspan="1" colspan="1">86.0&#x02009;&#x000b1;&#x02009;0.97<sup><italic>&#x003b2;</italic></sup></td></tr></tbody></table><table-wrap-foot><fn><p>Data are mean&#x02009;&#x000b1;&#x02009;SEM (<italic>N</italic>&#x02009;=&#x02009;6 per group). ANOVA&#x02009;+&#x02009;the Tukey test: <sup>b</sup><italic>p</italic> &#x0003c; 0.01 and <sup>a</sup><italic>p</italic> &#x0003c; 0.001 vs. the normotensive control group; <sup><italic>&#x003b4;</italic></sup><italic>p</italic> &#x0003c; 0.05, <sup><italic>&#x003b2;</italic></sup><italic>p</italic> &#x0003c; 0.01, and <sup><italic>&#x003b1;</italic></sup><italic>p</italic> &#x0003c; 0.001 vs. the hypertensive control group. AD100/AD200&#x02009;=&#x02009;extract doses 100 or 200&#x02009;mg/kg. LN&#x02009;=&#x02009;N-NAME.</p></fn></table-wrap-foot></table-wrap></floats-group></article>